Skip to content

AURELIEN MATEO: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

AURELIEN MATEO

BE 0680.698.488
NACE 01.620, Support activities for animal production
latest balance sheet 31-12-2024indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€77,977 to €94,927

Midpoint €85,040 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €71,204
Capitalised earnings €84,750 to €118,650
Indication €77,977 to €94,927

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 31-12-2024
Equity (10/15)
€71,204
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€71,204

Capitalised earnings

net result for the year (9904)
2024
€20,362
2023
-€3,317
2022
€18,550
2021
€23,817
2020
€22,517
Average result
€11,865
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€84,750 / €98,875 / €118,650

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 31 December 2024. Prepared on 28 September 2026 via checked.be. Indication, not a valuation or advice.